Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume -, Issue -, Pages -
Publisher
The Endocrine Society
Online
2022-02-09
DOI
10.1210/clinem/dgac043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats
- (2021) Kenji Takeda et al. BMJ Open Diabetes Research & Care
- Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
- (2021) Stephanie Kullmann et al. DIABETES CARE
- Canagliflozin Increases Calorie Intake in Type 2 Diabetes Without Changing the Energy Ratio of the Three Macronutrients: CANA-K Study
- (2020) Ikuro Matsuba et al. Diabetes Technology & Therapeutics
- Sodium/glucose cotransporter 2 is expressed in choroid plexus epithelial cells and ependymal cells in human and mouse brains
- (2020) Yoichi Chiba et al. NEUROPATHOLOGY
- Glucose transporters in brain in health and disease
- (2020) Hermann Koepsell PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Central nervous pathways of insulin action in the control of metabolism and food intake
- (2020) Stephanie Kullmann et al. Lancet Diabetes & Endocrinology
- Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
- (2019) Bernard Zinman et al. Lancet Diabetes & Endocrinology
- Weight loss variability with SGLT2 inhibitors and GLP‐1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities
- (2019) Emily Brown et al. Obesity Reviews
- Humans with obesity have disordered brain responses to food images during physiological hyperglycemia
- (2018) Renata Belfort-DeAguiar et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management
- (2018) Michaël J.B. van Baar et al. DIABETES CARE
- Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment
- (2018) Ichiro Horie et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
- (2018) Bernhard Ludvik et al. Lancet Diabetes & Endocrinology
- Weight loss associated with sodium-glucose cotransporter-2 inhibition: a review of evidence and underlying mechanisms
- (2018) P. C. Lee et al. Obesity Reviews
- fMRIPrep: a robust preprocessing pipeline for functional MRI
- (2018) Oscar Esteban et al. NATURE METHODS
- The dopamine motive system: implications for drug and food addiction
- (2017) Nora D. Volkow et al. NATURE REVIEWS NEUROSCIENCE
- The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
- (2017) Costantino Iadecola NEURON
- A core eating network and its modulations underlie diverse eating phenomena
- (2016) Jing Chen et al. BRAIN AND COGNITION
- Endogenous GLP1 and GLP1 analogue alter CNS responses to palatable food consumption
- (2016) Jennifer S ten Kulve et al. JOURNAL OF ENDOCRINOLOGY
- How Strongly Does Appetite Counter Weight Loss? Quantification of the Feedback Control of Human Energy Intake
- (2016) David Polidori et al. Obesity
- Neural vulnerability factors that increase risk for future weight gain.
- (2016) Eric Stice et al. PSYCHOLOGICAL BULLETIN
- Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
- (2016) Juan P Frías et al. Lancet Diabetes & Endocrinology
- Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
- (2015) Giulia Ferrannini et al. DIABETES CARE
- Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
- (2015) Jennifer S. ten Kulve et al. DIABETOLOGIA
- Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
- (2015) Feng Sun et al. Journal of Diabetes Research
- GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
- (2014) L. van Bloemendaal et al. DIABETES
- Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial
- (2014) Bruce A. Perkins et al. DIABETES CARE
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior
- (2014) Kyle S. Burger et al. PHYSIOLOGY & BEHAVIOR
- The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty
- (2013) Astrid Plamboeck et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
- (2013) L van Bloemendaal et al. JOURNAL OF ENDOCRINOLOGY
- Regional distribution of SGLT activity in rat brain in vivo
- (2012) Amy S. Yu et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors
- (2012) S. L. Dickson et al. JOURNAL OF NEUROSCIENCE
- The contribution of brain reward circuits to the obesity epidemic
- (2012) Eric Stice et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Weight Loss Induced by Chronic Dapagliflozin Treatment Is Attenuated by Compensatory Hyperphagia in Diet-Induced Obese (DIO) Rats
- (2012) James J. Devenny et al. Obesity
- Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
- (2011) M. A. Nauck et al. DIABETES
- fMRI reactivity to high-calorie food pictures predicts short- and long-term outcome in a weight-loss program
- (2011) Donna L. Murdaugh et al. NEUROIMAGE
- Long-Term Persistence of Hormonal Adaptations to Weight Loss
- (2011) Priya Sumithran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attentional Bias to Food Images Associated With Elevated Weight and Future Weight Gain: An fMRI Study
- (2011) Sonja Yokum et al. Obesity
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- Widespread reward-system activation in obese women in response to pictures of high-calorie foods
- (2008) Luke E. Stoeckel et al. NEUROIMAGE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now